Andrew Aguirre, MD, PhD, is a medical oncologist at Dana-Farber Cancer Institute, an Associate Professor of Medicine at Harvard Medical School and an Institute Member at the Broad Institute of Harvard and MIT. Dr. Aguirre is also the associate director of the Hale Family Center for Pancreatic Cancer Research and the co-director of the Center for RAS Therapeutics at Dana-Farber Cancer Institute. He leads a basic and translational cancer research laboratory that studies pancreatic cancer biology and RAS signaling with the goal of developing new therapeutic strategies for patients.